Protara Therapeutics, Inc.

TARA · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
207
SEC Filings

Business Summary

. Overview We are a New York City based clinical-stage biopharmaceutical company committed to advancing transformative therapies for the treatment of cancer and rare diseases. We were founded on the principle of applying modern scientific, regulatory or manufacturing advancements to established mechanisms in order to create new development opportunities. We prioritize creativity, integrity and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment opti...

Next Earnings

Q2 FY2026 — expected 2026-08-08

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTARAdiscussed_in_filing Cybersecurity
topic_mentionTARAdiscussed_in_filing Trusted Computing
topic_mentionTARAdiscussed_in_filing Blockchain & Crypto
topic_mentionTARAdiscussed_in_filing Regulation
topic_mentionTARAdiscussed_in_filing Healthcare & Bio
topic_mentionTARAdiscussed_in_filing Sovereign & Government
topic_mentionTARAdiscussed_in_filing Cybersecurity
topic_mentionTARAdiscussed_in_filing Trusted Computing
topic_mentionTARAdiscussed_in_filing Blockchain & Crypto
topic_mentionTARAdiscussed_in_filing Regulation
topic_mentionTARAdiscussed_in_filing Healthcare & Bio
topic_mentionTARAdiscussed_in_filing Sovereign & Government
topic_mentionTARAdiscussed_in_filing Cybersecurity
topic_mentionTARAdiscussed_in_filing Trusted Computing
topic_mentionTARAdiscussed_in_filing Blockchain & Crypto
topic_mentionTARAdiscussed_in_filing Regulation
topic_mentionTARAdiscussed_in_filing Healthcare & Bio
topic_mentionTARAdiscussed_in_filing Sovereign & Government
topic_mentionTARAdiscussed_in_filing Cybersecurity
topic_mentionTARAdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-102025-12-310001213900-26-025433EDGAR83K words
2025-03-052024-12-310001213900-25-020368EDGAR
2024-03-132023-12-310001213900-24-021982EDGAR
2023-03-082022-12-310001213900-23-018373EDGAR
2022-03-092021-12-310001213900-22-011208EDGAR
2021-03-112020-12-310001213900-21-014709EDGAR
2020-03-202019-12-310001171843-20-001860EDGAR
2019-03-132018-12-310001171843-19-001687EDGAR
2018-03-142017-12-310001171843-18-001934EDGAR
2017-03-162016-12-310001171843-17-001555EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001213900-25-107881EDGAR22K words
2025-08-112025-06-300001213900-25-073942EDGAR
2025-05-082025-03-310001213900-25-040811EDGAR
2024-11-122024-09-300001213900-24-096252EDGAR
2024-08-062024-06-300001213900-24-065380EDGAR
2024-05-022024-03-310001213900-24-038757EDGAR
2023-11-032023-09-300001213900-23-083013EDGAR
2023-08-032023-06-300001213900-23-062782EDGAR
2023-05-042023-03-310001213900-23-036113EDGAR
2022-11-032022-09-300001213900-22-069010EDGAR
2022-08-092022-06-300001213900-22-045922EDGAR
2022-05-052022-03-310001213900-22-024238EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001213900-26-035971EDGAR1K words
2026-03-100001213900-26-025432EDGAR
2026-02-240001213900-26-019617EDGAR
2025-12-150001213900-25-121687EDGAR
2025-12-080001213900-25-119242EDGAR
2025-12-030001213900-25-117577EDGAR
2025-11-190001213900-25-112383EDGAR
2025-11-100001213900-25-107873EDGAR
2025-08-110001213900-25-073937EDGAR
2025-06-120001213900-25-053844EDGAR

207 total filings indexed. 175 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001359931
TickerTARA
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 86bc7f2bb510d8add920163052388851b748050757a192d38fd33d09a6b864fa
parent: e6b828d0f1d344418080853a7bf303be5cc9ae747f403ec0b4cb595915c2afe3
content hash: 8b73364b7120eeb7e7809fdea332dfe9c0f6dcc62599b396fec9feef65c74c31
signed: 2026-04-13T04:47:43.301Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf